October 20, 2014
Community Engagement Forum Brings Sites and Researchers Together to Improve Efforts
New tools to improve communication, monitoring, and coordination introduced September 6, 2014
Results of Phase 3 Clinical Trial of New Tuberculosis Drug Regimen Published in New England Journal of Medicine
August 18, 2014
Novartis Provides Drug Candidate Compounds to TB Alliance
Exclusive worldwide license from Novartis includes a novel class of drugs that is active against drug sensitive and multi-resistant strains of tuberculosis July 30, 2014
TB Alliance Names Elana Robertson Senior Vice President, Market Access
Robertson Will Lead Initiatives to Accelerate Adoption of New TB Drug Regimens July 30, 2014
TB Alliance Appoints Willo Brock Senior Vice President, External Affairs
Brock Will Lead Resource Development, Advocacy, Community Engagement Efforts in Support of Promising Research Pipeline July 8, 2014
Over 50 million children infected with tuberculosis
A new study quantifying the global TB burden among children points to a huge undiagnosed reservoir of TB. May 13, 2014
TB Alliance Appoints Dr. Nader Fotouhi, Chief Scientific Officer
Fotouhi to guide organization's discovery-stage research and clinical trials of drug candidates April 22, 2014